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Abstract 
Preferential Crystallization (PC) is a popular process to separate enantiomers, however 
the nucleation and growth of the counter enantiomer during the process can compromise the 
enantiopurity of the final crystalline product. This research investigates the use of additives to 
inhibit the nucleation and growth of the counter enantiomer. In this study, we use L-
asparagine monohydrate (L-$VQÂ+2O) as the preferred enantiomer in crystallization from DL-
$VQÂ+2O solutions. Additives include both pure enantiomers of several related amino acid 
species. This allows investigation of differences in inhibition caused by additives that are of 
the same chirality and different chirality as the preferred enantiomer. The additives had no 
discernible effect on the solubility but had a small effect on the metastable limit, with 
additives tending to slightly widen the metastable zone but also make the zone widths more 
disperse. D-additives have a small effect on the growth rate of L-$VQÂ+2O but L-Asp and L-
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Glu strongly inhibit the growth rate of L-$VQÂ+2O in DL-$VQÂ+2O solution; there must also 
be a corresponding effect for D-Asp and D-Glu on D-$VQÂ+2O. Indeed, PC experiments 
showed that in order to obtain L-$VQÂ+2O from a PC while preventing the formation of D-
$VQÂ+2O, D-Asp and D-Glu are suitable additives, leading to high yield and purity of pure L-
$VQÂ+2O.  
 
1. Introduction  
Many products in pharmaceutical, food and agrochemical industries are chiral 
compounds. The two enantiomers of a chiral compound are two stereoisomers and the two 
molecules are non-superimposable mirror images [1]. The pair of enantiomers have identical 
physical and chemical properties (apart from the optical rotation) in achiral solvents but are 
different in biological activities [2]. In the chemical synthesis of chiral materials the product 
of the synthesis is usually a racemic mixture of enantiomers; 50% is the preferred enantiomer 
and 50% is the counter enantiomer. Normally, the counter enantiomer has no beneficial effect 
but does increase the drug loading on the body. In some cases the counter enantiomer is 
harmful; R-thalidomide was used as a sedative and sleeping drug for pregnant women, 
however, S-thalidomide was found to be teratogenic and caused birth defects in thousands of 
babies [3]. Therefore the separation of enantiomers is essential in many industries, but 
particularly in the pharmaceutical industry.  
There are many processes to separate enantiomers. Chiral membrane separation uses a 
chiral-modified membrane which allows the desired enantiomer to selectively diffuse through 
or adsorb onto the membrane [4]. Chiral chromatography separation uses an enantioselective 
chiral stationary phase to separate enantiomers [5,6]. However, crystallization has 
unprecedented selectivity and potentially leads to an enantiopure product within a single 
process step if the crystallization of the counter enantiomer can be avoided. This can be done 
through the formation of diastereomeric salts which changes the enantiomers to diastereomers 
which have different physical properties and enables separation by crystallization [7]. 
However, this requires an additional separation step to recover the resolving agent.  
Preferential crystallization (PC) is a single step process that is easy and low cost for 
separating enantiomers. This process is suitable for separation of a racemic mixture that is a 
conglomerate forming system, meaning the equilibrium product is a mechanical mixture of 
the two enantiomorphs [8]. PC achieves separation in a single process step through seeding 
the preferred enantiomer to the supersaturated racemic solution; the preferred enantiomer will 
crystallize at a higher rate than the counter enantiomer, and significant yield and enantiopurity 
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can be achieved if the nucleation and growth of the counter enantiomer from the 
supersaturated solution can be avoided. PC has been applied to chiral species such as glutamic 
acid [9], asparagine [10], threonine [11] and methionine hydrochloride [12]. However, this 
method has a serious problem which is the spontaneous nucleation and growth of the counter 
enantiomer. This may occur after prolonged batch times where the solution has a high 
supersaturation of the counter enantiomer in comparison to the preferred enantiomer [11]. 
Many researchers have tried to circumvent this problem, for instance by using coupled batch 
crystallizers ± crystallizing the preferred enantiomer in one crystallizer and the counter 
enantiomer in another crystallizer, with exchange of solution between the two crystallizers 
[13], coupled batch crystallizers with seeding of the preferred enantiomer in one crystallizer 
and allowing nucleation of the counter enantiomer in another crystallizer maintained at a 
different temperature [14, 15], coupled batch crystallizers with a membrane between the 
crystallizers to prevent transport of crystals from one crystallizer to another [16], and 
racemization of the solute species to equalize the concentrations of the preferred and counter 
enantiomer [17,18],  
Another way to circumvent the crystallization of the counter enantiomer is to use tailor 
made additives to inhibit the nucleation and growth of the counter enantiomer. This will be 
convenient if the scale of the resolution is such that a fully batch system is most suitable and 
crystallization or recycling of the counter enantiomer is not required. A tailor made additive is 
any additive which is intelligently designed to change the crystallization process in a desired 
way. It may inhibit either growth or nucleation, or more rarely promote growth or nucleation, 
or it may alter the shape or morphology of the crystals. Addadi et al. proposed the rule of 
reversal, which suggests that additives most easily adsorb on the surface of the crystal that has 
the same absolute configuration as the additive [19,20]. The rule thus states that the chiral 
additive will inhibit the crystallization of the enantiomorph similar in chirality to the additive. 
There are many studies about effect of tailor made additives to the crystallization such as 
effect of D- and L-lysine additives on DL-glutamic acid [9,21,22].  
We are interested in the technique of preferential crystallization using tailor made 
additives because it uses only a small amount of additive and is easier to operate than other 
techniques. However how the mechanism by which the additives affect the preferential 
crystallization, or more specifically the mechanism by which additives reduce the 
crystallization rate of the counter enantiomer is not known. The present research investigates 
the solubility and metastable zone width, and both the nucleation and crystal growth processes 
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in the presence and absence of additives in an attempt to determine which of the 
crystallization mechanisms is altered by the presence of the additive.  
Doki et al. investigated the effect of pure enantiomeric amino acid additives on the 
enantiomeric purity of asparagine crystals obtained from racemic solutions [23]. In these 
unseeded crystallizations they observed a significant delay in the crystallization of the counter 
enantiomer, indicating that asparagine is an interesting model compound to investigate the 
effect of chiral additives on asparagine PC. Therefore, following the rule of reversal, we 
further investigate the preferential crystallization process of L-asparagine monohydrate (L-
$VQÂ+2O) from DL-$VQÂ+2O by using D- and L-amino acid additives which have a similar 
structure to asparagine. We also investigate the efficiency and yield of the preferential 
crystallization when using additives. To explain the observed effects we separately study the 
effect of additives on the solubility, metastable zone width and the growth rate.  
 
2. Experimental Methods 
 
2.1 Materials 
DL-asparagine monohydrate (99+ wt%), L-asparagine monohydrate (99+ wt%) and D-
asparagine monohydrate (99+ wt%), were purchased from Sigma-Aldrich. D-(-)-aspartic acid 
(99+wt%), D-(-)-glutamic acid (99+wt%), D-valine (98+wt%), D-leucine (99 wt%), L-(+)-
aspartic acid (98+wt%), L-(+)-glutamic acid (99+wt%), L-valine (98+wt%), and L-leucine 
(99 wt%) were purchased from ACROS. These reagents were used without further 
purification. Deionized water was used as the solvent. 
 
2.2 Experimental Procedure 
2.2.1 Solubility and Metastable Zone Width 
The solubility and the metastable zone limit of L-$VQÂ+2O with and without additives 
were determined using the Crystal16 (Technobis, Amsterdam). Samples were prepared with a 
NQRZQFRQFHQWUDWLRQRI$VQÂ+2O in 1 g of water. To determine the clear point temperature 
(the temperature at which the suspension turns into a clear solution upon heating), the 
suspension in the vial was heated with a heating rate of 0.1°C/min up to 60°C to complete 
dissolution. The temperature at which the turbidity reached zero was recorded. To determine 
the cloud point temperature (the temperature at which the clear solution turns into a 
suspension upon cooling), the clear solution was subsequently cooled down to 2°C with a 
cooling rate of 0.1°C/min. The clear point temperature was taken as the saturation 
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temperature of the solution while the cloud point was taken as the metastable limit of the 
solution for the cooling rate used. The region between the saturation temperature and the 
highest metastable zone limit measured for a sample was taken as the metastable zone region. 
For the results, two or three measurements were performed subsequently with the same 
solution. 
  
2.2.2 Single Crystal Growth Rate Experiments 
Stock suspensions with various amounts of DL-$VQÂ+2O in the presence and absence of 
various additives were prepared at 30°C and heated up to 58°C to completely dissolve the 
solute. When needed, the solution was cooled to the crystallization temperature, 30°C. Nine 
crystals of L-$VQÂ+2O were attached by glue to a cover glass that was placed in a 50 cm3 
small cell which was temperature-controlled using a jacket on the cell which used water from 
a constant temperature bath. The experimental set up is shown in Fig. 1. The growth process 
of L-$VQÂ+2O was initiated when we added the solution to the cell. The size of the crystal was 
measured every 10 minutes until 80 minutes using a microscope and the DinoCapture 2.0 
program. We analyzed the concentration in the cell using an automatic digital refractometer 
(RFM 340, Bellingham+Stanley Ltd., UK). We investigated the growth rate of L-$VQÂ+2O 
crystals using supersaturation ratios (S) of 1.05, 1.10 and 1.15 for L-$VQÂ+2O and DL-
$VQÂ+2O solutions. For investigation of the effect of additives we used 3 mol% of additives 
based on the total concentration of DL-AsnH2O in solution at a supersaturation ratio (S) of 
1.1. 
 
                   (a)       (b) 
Figure 1. The experimental set up of growth rate experiment (a) crystal growth cell and (b) 
experimental set up 
 
2.2.3 Preferential Crystallization 
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The preferential crystallization of L-$VQÂ+2O (the preferred enantiomer) from DL- 
$VQÂ+2O was performed, and additives were used to inhibit D-$VQÂ+2O (the counter 
enantiomer). We prepared a solution of DL-$VQÂ+2O with a supersaturation ratio (S) of 1.3 at 
30°C in 40 g of water in a 50 mL crystallization vessel with jacket to control the temperature. 
Additives were added to the solution at 5 mol% compared to the total amount of DL-
$VQÂ+2O. The solution was heated to 50°C to completely dissolve the crystalline material. 
Subsequently, the solution was cooled down rapidly to the crystallization temperature of 
30°C. L-$VQÂ+2O seeds, 0.02 g (300-500 micron) were added into the solution the moment 
the crystallization temperature reached 30°C. The process was stopped at a given time and the 
suspension was vacuum filtered to obtain crystal samples at different times from 1 h to 7 h 
after the addition of seeds. The solid product was kept in a desiccator for drying. The solid 
products were analysed by HPLC (1260 Infinity, Agilent Technologies) with a Chirobiotic T 
column. The HPLC analysis was performed at 25°C using a 70:30 vol% ethanol:water 
mixture as a mobile phase at 0.4 mL/min, and using UV detection at 205 nm. The injection 
YROXPHZDVȝ/Under these conditions the detection time for L-$VQÂ+2O was 18 min and 
the retention time of D-$VQÂ+2O was 27 min. 
 
3. Results and Discussion 
First the solubility and metastable zone limit are presented, followed by the crystal 
growth rate experiments in the presence and absence of the additives. Finally, preferential 
crystallization of L-$VQÂ+2O in DL-$VQÂ+2O with and without additives is discussed. 
 
3.1 Solubility and Metastable Zone Width 
Asparagine monohydrate is a conglomerate forming system [24] which is suitable for the 
PC process [6]. The solubility and metastable zone width of L-$VQÂ+2O, DL-$VQÂ+2O and L-
$VQÂ+2O with 5% additives is shown in Figure 2 where the solubility values are given in mg 
AsnÂH2O/g H2O. The solubility of L-$VQÂ+2O increases with increasing temperature. The 
solubility of DL-$VQÂ+2O is slightly more than twice the L-$VQÂ+2O solubility and thus only 
approximately follows the Meyerhoffer solubility rule [25]. The current data agrees well with 
the single data point for aqueous systems of Orella and Kirwan [26], 28.7 mg L-AspÂH2O/g 
H2O at 25°C. However the data for the L-AsnÂH2O/g H2O is around 4-5% lower than 
equivalent results of Dalton and Schmidt [27]: however that study is over 80 years old, and 
perhaps the purification of the amino acids was more difficult at that point. Solubility data 
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over the entire range of temperatures measured agree very well with the recent data of Binev 
et al. [28].    
Since D-$VQÂ+2O and L-$VQÂ+2O are a pair of enantiomers, the solubility and metastable 
zone width (MSZW) are the same for these species (in the absence of chiral additives, or if 
equivalent chiral additives are used). The solubility of D-$VQÂ+2O with D-enantiomer 
additives is almost identical to the solubility of pure D-$VQÂ+2O (by comparison to the 
solubility of pure L-$VQÂ+2O). It was found that the D-enantiomer additives do have an effect 
on the MSZW of D-$VQÂ+2O. The results are very scattered, but the additives appear to 
slightly increase the MSZW of D-$VQÂ+2O, and also increase the range of possible values. 
Equivalent effects would be seen for the effect of L-additives on L-$VQÂ+2O. The MSZWs for 
the DL-AsnÂH2O systems are significantly larger than those from the previous studies [28]. 
This is curious since both studies used identical techniques and equipment (the Crystal16, 
multiple reactor system). It is known that the MSZW is reliant on the nucleation rates of the 
solute, and so is very sensitive to small changes in the properties of the measurement device 
and also to the properties of the solution, for instance trace levels of impurity and dust.  
 
Figure 2. The solubility and metastable limit of L-/DL-$VQÂ+2O with and without additives 
in water. Solubility points consist of L-$VQÂ+2O ( ), DL-$VQÂ+2O (d), D-$VQÂ+2O 
with D-Asp (), D-$VQÂ+2O with D-Leu (), D-$VQÂ+2O with D-Glu (S), D-
$VQÂ+2O with D-Val (¥), and cloud points consist of L-$VQÂ+2O ({), DL-$VQÂ+2O 
(U), D-$VQÂ+2O with D-Asp (), D-$VQÂ+2O with D-Leu (), D-$VQÂ+2O with D-




3.2 Crystal Growth Rate of L-$VQÂ+2O in L-/DL-$VQÂ+2O with additives 
The shape of crystals of L-$VQÂ+2O grown from aqueous solution at various times is 
shown in Figure 3. We used the length of the principal axis of the crystal to find the crystal 
growth rate. The crystal growth rate of each L-$VQÂ+2O crystal in solution can be found from 




Figure 3. Crystal shape of L-$VQÂ+2O in DL-$VQÂ+2O with supersaturation, S equal to 1.1 at 







Figure 4. Relationship between crystal size (length) of L-$VQÂ+2O and time in supersaturated 
solution (S = 1.1) of (a) L-$VQÂ+2O and (b) DL-$VQÂ+2O at 30°C.  
 
The crystal growth rate of L-$VQÂ+2O crystals in supersaturated solutions of L- and DL-
$VQÂ+2O, and DL-$VQÂ+2O with D/L- additives can be plotted as growth rate distributions, 
growth rate frequency vs growth rate of L-$VQÂ+2O, as shown in Figure 5, and also modeled 
based on the normal distribution, eq 1.  ݂ீ ሺܩሻ ൌ ܽ  ?  ൬ሺீିீబሻమଶఙಸమ ൰      (1) 
where fG is the growth rate frequency, G is the crystal growth rate, G0 is the mean growth rate 
of the distribution, ıG is the standard deviation of the growth rate distribution, and a is a 
parameter relating only to the total number of samples in the distribution [29]. While there is 
no a priori knowledge of the shape of the growth rate distributions, the distributions found are 
relatively narrow and fit the normal distribution quite well. 
The fitting parameters for the crystal growth rate of L-$VQÂ+2O crystals in various 
supersaturated solutions of L- and DL-$VQÂ+2O are shown in Table 1 and in supersaturated 
solutions of DL-$VQÂ+2O with 3 mol% of D-/L- additives in Table 2. 
 
Table 1: Fitting parameters for the crystal growth rate distribution of L-$VQÂ+2O grown in 
solutions of L- and DL-$VQÂ+2O in various supersaturation.  
 
S L-AsnͼH2O solution DL-AsnͼH2O solution 
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1.05 1.1 1.15 1.05 1.1 1.15 
Go ȝPPLQ 0.51 0.96 1.41 0.29 0.60 0.89 
ıG 0.09 0.11 0.12 0.07 0.11 0.18 
R2 0.9972 0.9835 0.9360 0.9985 0.9423 0.9765 
 
Table 2: Fitting parameters for the crystal growth rate distribution of L-$VQÂ+2O grown in 
solutions of DL-$VQÂ+2O without and with 3 mol% (based on total concentration of DL-
AsnH2O) of various additives at a supersaturation S = 1.1.  
Type of additives no additives D-Asp D-Glu D-Leu D-Val L-Asp L-Glu L-Leu L-Val 
Go ȝPPLQ 0.60 0.39 0.47 0.69 0.60 0.19 0.28 0.62 0.73 
ıG 0.11 0.07 0.09 0.11 0.08 0.06 0.06 0.12 0.07 








Figure 5.  Relationship between growth rate frequency and growth rate of L-$VQÂ+2O crystals 
in a solution with supersaturation, S = 1.1 of (a) L-$VQÂ+2O (b) DL-$VQÂ+2O at 
30°C.  
 
The growth rate of L-$VQÂ+2O in L-$VQÂ+2O solution was the highest; for the same 
supersaturation of L-$VQÂ+2O the growth from DL-$VQÂ+2O solutions was substantially 
reduced, with an almost 50% reduction in growth rates at low supersaturation values. One 
explanation for this difference is that the counter enantiomer acts as an inhibitor to the growth 
of the preferred enantiomer. It is possible that even in compounds where the conglomerate is 
the stable crystal form, the association of the preferred and counter enantiomer (as would be 
seen in the racemate form) is still strong enough that the counter enantiomer of the additive 
can also adsorb to the surface of the crystal and inhibit the growth of the conglomerate form. 
Another possible explanation is that racemic dimers of Asn (associations of D- and L- 
molecules) in solution hinders the supply of L- monomers to the surface of the crystal and 
thus lowers the crystal growth rate.   
From Table 2, the mean growth rate of L-Asn·H2O with D-Val and L-Leu additives are 
not statistically different from the growth rate without additives. Use of D-Leu as an additive 
increases the growth rate, however the change is only slightly larger than the 95% confidence 
limits. Use of L-Val as an additive increases the growth rate of L-Asn by a statistically 
significant amount. The reason for this is not known although the additive appears to have no 
significant effect on the solubility of L-Asn. It is possible that the molecule interrupts the 
associations between D- and L-Asn molecules in solution. D-Glu, D-Asp, L-Glu and L-Asp 
additives significantly reduced the crystal growth rate of L-$VQÂ+2O. This is to be expected 
because of the greater similarity of the side chains of aspartic acid and glutamic acid to 
asparagine, in comparison to the side chains of valine or leucine. However, there is a more 
significant effect of additives of the same chirality as the growing crystal; the effect of L-Glu 
and L-Asp on L-$VQÂ+2O was greater than the D-Glu and D-Asp additives because L-Glu and 
L-Asp additives have the same absolute configuration as L-$VQÂ+2O. These additives are 
therefore likely to adsorb on the growing surface of L-$VQÂ+2O and inhibit the propagation of 
the growth steps on the crystal.  
For this experiment, we measured the growth in the length of the principal axis of the 
crystal, but the growth rate based on the spherical average diameter can be derived from this 
value based on the shape of the crystal. In the case investigated here it was found that there is 
minimal change in the shape of the crystal as the growth progresses even in experiments using 
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additives, and therefore it seems that the additives cause a similar inhibiting effect for all 
important growth surfaces of the crystal. 
Here L-Asn was used as the crystallizing species for convenience ± it is easier to obtain 
commercially than D-Asn. In the preferential crystallizations of L-AsnÂH2O we use D-Asp 
and D-Glu to inhibit growth of D-AsnÂH2O.  
 
3.3 Preferential crystallization of L-$VQÂ+2O with D-Aspartic acid additives 
The preferential crystallization (PC) of L-$VQÂ+2O from DL-$VQÂ+2O with and without 
additives was studied. The enantiomeric excess e of the produced crystals and yield y of the 
PC were measured to show the effectiveness of the additives. 
                                                 
  u  u 
L D L D
L D L D
C C A A
e 100% 100%
C C A A                                  (2) 
Where CL is the concentration of L-Asn·H2O in the solid product (g L-$VQÂ+2O/g solid), CD 
is the concentration of D-Asn·H2O in the solid product, AL and AD are the peak areas of L-
Asn·H2O and D-Asn·H2O from the solid product in the HPLC chromatogram.  ݕ ൌ ௠೟௠೟೓ ൈ ? ? ? ?(3) 
Here, mt is the mass of preferred enantiomer produced (which does not include the mass of 
the counter enantiomer in the product if the e is less than 100%) and mth is maximum mass of 
the preferred enantiomer obtainable at equilibrium (again, excluding the counter enantiomer). 
Since a mass ms of seed crystals was introduced at the start of the preferential crystallization 
resulting in a mass mp of the preferred enantiomer product, the yield is further defined using 
mt =  mp - ms in eq. 3.  ݕ ൌ ݉௣  െ ݉௦݉௧௛ ൈ ? ? ? ? 
 
Figures 6-7 show the yield y and enantiomeric excess e of product in time respectively of 
the PC of L-Asn·H2O in DL-Asn·H2O with and without additives. The yield of the PC of L-
Asn·H2O with and without additives increases with time. The yield of the PC of L-Asn·H2O 
without additives can reach 60% within 7 h. However, pure L-Asn·H2O product can only be 
obtained within the initial 4 h, with a yield of only 25% at this time: After 4 h of the 
crystallization nucleation and growth of D-Asn·H2O occurs decreasing the enantiomeric 
excess e.  
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Since the growth of the L-Asn·H2O crystals was not close to completion at this time, the 
crystallization of D-Asn·H2O should be inhibited to prolong the crystallization time through 
the use of additives. In the case of D-Leu and D-Val additives, similar yield and enantiomeric 
excess results are obtained compared to the PC without additives; this shows that they are not 
effective in inhibiting the crystallization of D-Asn·H2O. However, D-Glu and D-Asp can 
extend the time period during which there is no crystallization of D-Asn·H2O, which 
increases the period during which pure L-Asn·H2O can be formed to longer than 7 h and 10 h 
respectively.  
Although the time period of preferential crystallization is increased, the yield of L-
Asn·H2O is lower at the same crystallization time compared to the case where no additive is 
used. This indicates that these additives also seem to inhibit the crystallization of L-Asn·H2O, 
which is consistent with the growth rate experiments. Nevertheless, the maximum yield of 
pure L-Asn·H2O from PC with D-Glu additive is 30%, and with D-Asp additive is more than 
44%, as shown in Figure 8, which is higher than the potential yield in the absence of 
additives. Therefore, the additives are helpful for the PC process in purity and yield. It is 
interesting that the main effect seen in the PC experiments was a significant increase in the 
induction time required for noticeable nucleation of the counter enantiomer while the MSZW 
experiments showed that the additives had only a small effect on the zone width. This may be 
due to the higher supersaturations at which crystals appear in the MSZW measurements 
compared to the PC and growth experiments. At these higher supersaturations additives might 
be less effective in blocking the crystal growth and since the MSZW is at least partially 
determined by growth no substantial effects of the impurities were measured. Since the 
MSZW is determined by nucleation and subsequent growth while no substantial effects of the 
impurities on the MSZW were measured this suggests that nucleation only occurs at relatively 
high supersaturations at which the effect of the impurity on the growth is absent.  
To increase yield and prolong the period for which the enantiomeric excess is close to 
100% for the system using PC with additives, more seed crystals can be used. The current PC 
experiments were performed to investigate the mechanisms on which the additives act in 
order to improve the performance of the PC systems. In order to optimize PC processes it is 
also necessary to consider optimization in terms of all tunable parameters, including additive 






Figure 6.  The yield y of L-Asn·H2O in the crystal phase during a preferential crystallization 
(PC) of L-Asn·H2O from DL-Asn·H2O in water in absence of additive (z), with 
5% mol of D-Asp (), with 5% mol of D-Glu (d), with 5% mol of D-Val (U), 
with 5% mol of D-Leu (), yield of D-Asn·H2O from DL-Asn·H2O in water in 
absence of additive ({). The lines are a guide to the eye. 
 
 
Figure 7. The enantiomeric excess e of L-Asn·H2O in the crystal phase during a preferential 
crystallization (PC) of L-Asn·H2O from DL-Asn·H2O in water in absence of 
additives (z), with 5% mol of D-Asp () with 5% mol of D-Glu (d), with 5% 






Figure 8. The relationship between enantiomeric excess e and yield y of L-Asn·H2O from 
DL-Asn·H2O in water in absence of additive (z), with 5% mol of D-Asp (), with 
5% mol of D-Glu (d). The lines are a guide to the eye. 
 
Conclusions 
The tested D-amino acids have almost no effect on the solubility of D-Asn·H2O but have 
a slight effect on the metastable zone width of D-Asn·H2O, largely increasing the scatter or 
uncertainty of this zone. The growth rate of L-Asn·H2O strongly decreases when using L-Asp 
and L-Glu additives in DL-Asn·H2O solutions. The converse must also be true, that D-Asp 
and D-Glu inhibit crystallization of D-Asn·H2O: These additives effectively prevent the 
crystallization of the counter enantiomer in the preferential crystallization of L-Asn·H2O. The 
success of these additives is likely due to the similarities in their side chains in comparison to 
asparagine. Leucine and valine have far less effect as additives; these two molecules have side 
chains that are alkanes, which are much less compatible with the side chain of asparagine 
which contains both carbonyl and amine functionality. However, at the same crystallization 
time the yield of L-Asn·H2O decreases when D-Glu and D-Asp were used as additives. 
Therefore, the D-additives not only influence the crystallization of D-Asn·H2O but also 
influence the crystallization of L-Asn·H2O. Nevertheless, the yield of L-Asn·H2O at the end 
of the period during which pure L-Asn·H2O can be produced is higher when using D-Asp and 
D-Glu additives, and can in principle be increased by adding more seed crystals. Therefore, 
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